AI Verdict
MRK has stronger fundamentals based on our AI analysis.
COR vs MRK Fundamental Comparison
| Metric | COR | MRK |
|---|---|---|
| Revenue | $164.3B | $16.3B |
| Net Income | $2.2B | $-4.2B |
| Net Margin | 1.3% | -26.0% |
| ROE | 64.8% | -9.2% |
| ROA | 2.7% | -3.3% |
| Current Ratio | 0.95x | 1.30x |
| Debt/Equity | 3.65x | 1.02x |
| EPS | $11.27 | $-1.72 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
COR vs MRK: Frequently Asked Questions
Is COR or MRK the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MRK has stronger fundamentals. COR is graded C (74% confidence) while MRK is graded B (78% confidence). This is not investment advice.
How does COR compare to MRK fundamentally?
Cencora, Inc. has ROE of 64.8% vs Merck & Co., Inc.'s -9.2%. Net margins are 1.3% vs -26.0% respectively.
Which stock pays higher dividends, COR or MRK?
COR has a dividend yield of N/A or no dividend while MRK has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in COR or MRK for long term?
For long-term investing, consider that COR has a C grade with 74% confidence, while MRK has a B grade with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about COR vs MRK?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For COR vs MRK, the AI consensus favors MRK based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.